Meet Sonavex, the winner of our first Annual Crab Trap Competition! The competition was the final part of the two-day 2016 BioHealth Capital Region Forum, during which world renowned speakers, industry luminaries and commercial giants convened to highlight the accomplishments of today and chart our successes of tomorrow.
The biohealth industry in Maryland, Virginia and DC needs a strong identity and brand that will help it grow and attract the best talent in the world. At a regional conference on April 18, the community announced a new name and tagline, along with a wordmark:
To complete the logo, an icon is needed that captures the spirit of the industry and the region.A competition is underway for the icon design. Anyone from an organization (college, company, PR firm, etc.) based in Maryland, Virginia or DC may submit an entry. The deadline for submissions is May 31, 2016. The winner will receive $5,000.More information and submission instructions are at http://www.competition.regionalbiotechforum.com/
Emergent BioSolutions has filed a supplemental Biologics License Application with the U.S. Food and Drug Administration to scale up production of its anthrax vaccine BioThrax. BioThrax is the only FDA-approved anthrax vaccine for humans. It’s primarily produced for and purchased by the U.S. military, and has been in distribution since the 1970s.
Our annual Industry Awards Celebration recognizes the leaders and innovators in the technology and life science communities from Maryland and the surrounding regions. The evening brings over 900 technology, life science, government, academia, and supporting businesses together at one place, at one time for Maryland’s best night of networking.
The Energetics Technology Center, Inc. (ETC) and the Army Research Labs (ARL), under its recent Partnership Intermediary Agreement (PIA), are pleased to announce the opening of a new incubator , TechFire ARL, in Silver Spring, MD. This new facility, located in the former National Labor College at 10000 New Hampshire Avenue, will focus on providing start-up and joint collaborative workspace for entrepreneurs, ARL researchers and university faculty.
Roger Jeffs will step down as president and co-CEO at United Therapeutics Corp. as part of an executive shakeup at one of Greater Washington’s largest bioscience firms.
Baltimore-based Sisu Global Health has announced $200,000 in funding from the Abell Foundation to further progress of its medical device created to be used in the developing world.
Today, Stewart Edelstein, executive director of the Universities at Shady Grove, released the following statement:
“On behalf of the entire Universities at Shady Grove (USG) community, I want to thank the Maryland General Assembly and Governor Hogan for reinstating $36.7 million in funding for the construction of our Biomedical Sciences and Engineering Education (BSE) facility. With this secured funding, the Universities at Shady Grove plans to break ground later this year on the new facility.
The old adage that money doesn’t change everything could well be said of this year’s Top 10 U.S. biopharma clusters as listed by GEN. Nearly all regions saw significant increases in NIH funding (thanks to the $2 billion boost agreed upon by Congress for the current fiscal year) and in venture capital or “VC” funding (thanks to a market that was bullish on biopharma until this fall).
MedImmune, the global biologics research and development arm of AstraZeneca, today announced that it has achieved a significant scientific milestone by publishing three manuscripts in Nature Immunology that advance the understanding of the immune system and highlight underlying mechanisms in two little-understood disease areas — chronic obstructive pulmonary disease (COPD) and systemic lupus erythematosus (SLE). These include:
Baltimore is in line to have two schools that offer a career pathway program developed by IBM.
Gov. Larry Hogan signed a bill into law on Tuesday that provides framework and funding for P-TECH in the state. The Pathways in Technology Early College High School program follows a model of partnering with companies to provide students with STEM skills so they are immediately ready for a job. Starting the program in 9th grade, the students receive a high school diploma, associate’s degree and additional workforce training.
University of Maryland will break ground Saturday on a new computer science building made possible by a $31 million donation from a student-turned-technology entrepreneur.
American University is launching a new Center for Innovation in the Capital on Wednesday, part of its ongoing efforts to position itself as a source for business intelligence in Greater Washington.
The University of Maryland, Baltimore (UMB) held a grand opening for its Community Engagement Center in West Baltimore at 1 N. Poppleton St. on Saturday, April 16, including a spring community festival to introduce the neighborhood to the center and its valuable services. Maryland’s First Lady Yumi Hogan was a guest at the grand opening, assisted with the ribbon-cutting, and spent the day with community members at the spring festival.
How can we detect ovarian cancer before it’s too late? Can we make wounds heal faster? What are the alternatives to bariatric surgery for people with type 2 diabetes? Is there a way to reduce complications and cost in reconstructive surgery?
US-based medical devices firm Becton, Dickinson and Co. (BD) Monday said it will introduce a malaria detection method developed by Israel’s Sight Diagnostics Ltd (SightDX) in India, which will make a diagnosis in just in four minutes.
Universities traditionally measure their impact on entrepreneurship locally. At last month’s Global Entrepreneurship Congress (GEC), Bill Aulet from the Massachusetts Institute of Technology (MIT) reminded us that in a world where national boundaries are porous to both innovation and knowledge creation, assessing our impact globally can be a strong driver of collective performance improvement.
The Biotechnology Innovation Organization (BIO), the National Science Foundation (NSF) and the National Institutes of Health (NIH) today announced an agreement to feature Small Business Innovation Research (SBIR)-funded early-stage biomedical companies in an expanded Innovation Zone at the 2016 BIO International Convention. The Innovation Zone companies, focused on drug discovery, diagnostics and other therapeutic platform technologies, will have dedicated exhibit space and participate in BIO’s One-on-One Partnering™. Select companies will make 15-minute company presentations in the BIO Business Forum.
VividCortex, the database performance monitoring company that helps enterprises understand and optimize workloads across hybrid, distributed databases, today announced it has raised an additional $4.5 million in a Series A funding. The fast-growing company, which is profitable and grew revenues 8x last year, will use the funds to accelerate product development and sales.
AbbVie will buy venture-backed startup Stemcentrx for $5.8 billion, beefing up the biopharma giant’s portfolio of cancer drugs.
The sale could be worth $4 billion more if San Francisco-based Stemcentrx meets development milestones. Plus, as Business Insider reported, the startup has $400 million in the bank, potentially making the entire deal worth $10.2 billion.
Biopharmaceutical research has never been for the faint of heart. For small biotech companies working on the absolute edge of innovation, one clinical trial can literally mean the difference between closing up shop or commercializing a breakthrough, life-saving medicine. And even for big pharmaceutical companies, setbacks have always been inevitable – the nature of discovery means that success comes only after years of trial and error.
If academic discoveries turn out to be wrong, one drug company wants its money back.
That’s the tough-minded proposal floated today by the chief medical officer of Merck & Co., one of the world’s 10 largest drug companies, as a way to fix the “reproducibility crisis,” or how many, if not most, published scientific reports turn out to be incorrect.
May 8-11, 2016 – Grand Hyatt Washington DC in Washington, DC
Health Datapalooza is the gathering place for people and organizations creating knowledge from data and pioneering innovations that drive health policy and practice, and generate market value. Conceived as part of a public/private movement to liberate and use health data, the Datapalooza continues its tradition of engaging patient and consumer voices, and bringing national and international leaders from the C-levels of business and government together for engaging discussions.
We’re excited to invite you to join us for the 2016 Health Datapalooza – the meeting that brings data to life in ways that matter in health and health care. This year’s meeting finds us even closer to the reality of using data, analytics, and technology to re-define how we deliver and pay for health care. Come hear how data sharing, use, and transparency fuels innovative applications and business models that are building momentum towards a vibrant health information economy that drives high value health care.
A simple blood test to detect early signs of cancer. A noninvasive way to screen pregnancies for common genetic conditions. An app store for your genetic information. Illumina, a San Diego-based gene-sequencing hardware and software behemoth with a market capitalization of $22 billion, is working on all these initiatives—and more.
University tech transfer offices play a central role in the biotech ecosystem, as the successful commercialization of an academic discovery is the aspiration of many young startups. Navigating–and optimizing–this tech transfer process is therefore critical to the health of the biotech sector.
Incubators aren’t just for startups and entrepreneurs with a business idea. A new film incubator at Johns Hopkins University will look to cultivate new ideas for producing films and give a voice to local filmmakers and visual artists. The program, called the Bold Voices, New Paradigms Incubator, is part of the Saul Zaentz Innovation Fund in Film and Media Studies, which was launched by a $1 million grant from the Saul Zaentz Charitable Foundation.
Hello Tomorrow is a global non-profit headquartered in Paris that aims to accelerate science & tech innovation by empowering startups with cash prizes and connections with investors and industrials. It was created in 2011 by Xavier Duportet & Arnaud de la Tour. Hello Tomorrow is supported by the French public and private sectors, but remains an independent organization governed by entrepreneurs.
Novartis (NOVN.S) is discussing options with banks for selling its near $14 billion (9.7 billion pounds) stake in rival Roche (ROG.S), potentially providing cash for new deals, though a sale is not imminent, according to two people familiar with the situation.
Merely 5 percent of healthcare organizations worldwide are “operating at the highest level of digital health innovation proficiency and expertise,” according to a report from digital health consulting firm Enspektos. That means the vast majority have yet to scale and share their innovations, even within their own walls.
Dr. Jay Bradner, a decorated cancer researcher from the Dana-Farber Cancer Institute, turned heads last year when he accepted a top job at Novartis, one of the world’s largest drug makers. Academics jump to industry all the time, but Bradner made his name with a move pharma almost never makes: When he discovered a potentially cancer-fighting molecule, he just gave it away.
Currently live on SBIR.gov , are FY 2016 Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) grant and contract funding opportunities from NSF, DOD, and HHS.
If you’re an innovator, entrepreneur, researcher, or small technology firm, looking to engage in high-tech growth entrepreneurship and seeking non-dilutive funding opportunities to facilitate your necessary R&D prototype development, then SBIR.gov should be one of your first reference points of interest.
While speakers at the first day of Smithsonian magazine’s fourth annual “Future is Here” festival shared their thoughts on subjects as diverse as computer programming, the Zika virus, human space exploration, the future of the internet and the state of global fisheries, they all shared a common thread: there’s hope. Never give up—even if you have to wait a long time.
AstraZeneca has received Food And Drug Administration approval for one product, and entered into a deal to sell the U.S. rights to another. The FDA granted marketing approval to Bevespi Aerosphere, a maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease.
The D.C.-based startup incubator and seed fund signed an agreement to open an outpost at the Dubai Museum of the Future Foundation, a new organization formed to promote innovation in the United Arab Emirates.
One of the first things a new developer in healthcare quickly realizes is integrating and launching your application on top of medical data can be a total nightmare and often a showstopper. There are hundreds of electronic medical record (EMR) vendors and every implementation has a different “flavor” of a handful of competing standards.
The information contained in this website and newsletters is for general information purposes only. The information is provided by BioHealth Innovation via its newsletters, but not written or endorsed in any way by BioHealth Innovation unless otherwise noted. While we endeavor to keep the information up to date and correct, we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information, products, services, or related graphics contained on the website for any purpose. Any reliance you place on such information is therefore strictly at your own risk.
